Panoptes Pharma GesmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Panoptes Pharma GesmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11303
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥100,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Panoptes Pharma GesmbH (Panoptes Pharma) is a biotech company that develops small molecule based therapies to treat severe eye diseases. The company also develops products in the therapeutic areas of uveitis, viral conjunctivitis, and further indications. It concentrates on a new treatment for autoimmune uveitis, which is a disease that is one of the major causes of blindness. The company’s therapies provide treatment of autoimmune uveitis, adenoviral conjunctivitis, inflammatory and other viral indications. It conducts drug discovery programs through structure-based docking approach with several virtual compounds. Panoptes Pharma is headquartered in Vienna, Austria.

Panoptes Pharma GesmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Panoptes Pharma GesmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Panoptes Pharma GesmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Panoptes Pharma GesmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Panoptes Pharma GesmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Panoptes Pharma GesmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Panoptes Pharma GesmbH, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Panoptes Pharma Acquires Patents To Treat Eye Diseases From 4SC Discovery 10
Venture Financing 11
Panoptes Pharma Raises Funds through Venture Financing 11
Panoptes Pharma Raises US$1.62 Million In Seed Financing 12
Licensing Agreements 13
Panoptes Pharma Enters into Licensing Agreement with Mediolanum Labs 13
Panoptes Pharma GesmbH – Key Competitors 14
Panoptes Pharma GesmbH – Key Employees 15
Panoptes Pharma GesmbH – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Panoptes Pharma GesmbH, Pharmaceuticals & Healthcare, Key Facts 2
Panoptes Pharma GesmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Panoptes Pharma GesmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Panoptes Pharma GesmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Panoptes Pharma GesmbH, Deals By Therapy Area, 2012 to YTD 2018 8
Panoptes Pharma GesmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Panoptes Pharma Acquires Patents To Treat Eye Diseases From 4SC Discovery 10
Panoptes Pharma Raises Funds through Venture Financing 11
Panoptes Pharma Raises US$1.62 Million In Seed Financing 12
Panoptes Pharma Enters into Licensing Agreement with Mediolanum Labs 13
Panoptes Pharma GesmbH, Key Competitors 14
Panoptes Pharma GesmbH, Key Employees 15

List of Figures
Panoptes Pharma GesmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Panoptes Pharma GesmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Panoptes Pharma GesmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Panoptes Pharma GesmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Panoptes Pharma GesmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Panoptes Pharma GesmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Panoptes Pharma GesmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Panoptes Pharma GesmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Panoptes Pharma GesmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • OMV AG:企業の戦略・SWOT・財務情報
    OMV AG - Strategy, SWOT and Corporate Finance Report Summary OMV AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Apotex, Inc.:企業の戦略・SWOT・財務情報
    Apotex, Inc. - Strategy, SWOT and Corporate Finance Report Summary Apotex, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Citic Resources Holdings Limited:企業の戦略・SWOT・財務分析
    Citic Resources Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Citic Resources Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Bangkok Bank Public Co Ltd:企業の戦略・SWOT・財務情報
    Bangkok Bank Public Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Bangkok Bank Public Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Kawasaki Heavy Industries Ltd (7012):企業の財務・戦略的SWOT分析
    Kawasaki Heavy Industries Ltd (7012) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Merit Medical Systems Inc (MMSI):医療機器:M&Aディール及び事業提携情報
    Summary Merit Medical Systems, Inc. (Merit Medical) offers a wide range of single-use medical devices for interventional and diagnostic procedures. The company’s products include inflation devices and accessories, diagnostic and therapeutic catheters, diagnostic and hydrophilic products, thrombolyti …
  • Heat Biologics Inc (HTBX):企業の財務・戦略的SWOT分析
    Heat Biologics Inc (HTBX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Pioneer Natural Resources Co (PXD):企業の財務・戦略的SWOT分析
    Pioneer Natural Resources Co (PXD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Sumitomo Heavy Industries, Ltd.:企業の戦略・SWOT・財務情報
    Sumitomo Heavy Industries, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Heavy Industries, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Satrec Initiative Co., Ltd.:企業の戦略・SWOT・財務分析
    Satrec Initiative Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Satrec Initiative Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Universal Power Group Inc (UPGI):企業の財務・戦略的SWOT分析
    Summary Universal Power Group Inc (UPG) a subsidiary of UPGI Holdings Inc, is a provider of electric mobility products. The company through its subsidiaries supplies and distributes batteries and related power accessories. It offers sealed lead-acid batteries, ap series batteries, hc series batterie …
  • Sunquest Information Systems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Sunquest Information Systems Inc (Sunquest), a subsidiary of Roper Technologies, is a healthcare information technology (IT) company that provides diagnostic informatics solutions to laboratories and healthcare organizations worldwide. The company offers laboratory informatics such as labora …
  • Companhia Paranaense de Energia SA (CPLE6):電力:M&Aディール及び事業提携情報
    Summary Companhia Paranaense de Energia SA (Copel) is an integrated electric utility. It generates, transmits, distributes and sells electricity. The company produces electricity from hydro, wind, and thermal sources. Copel explores oil and natural gas; and distributes natural gas. It holds rights t …
  • NCsoft Corp (036570):企業の財務・戦略的SWOT分析
    NCsoft Corp (036570) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Pharmacosmos AS:製薬・医療:M&Aディール及び事業提携情報
    Summary Pharmacosmos AS (Pharmacosmos) is a drug discovery and development company that manufactures and markets medicines for the treatment of iron deficiency anaemia in humans and animals. The company offers human iron therapy, veterinary iron therapy, pharmacosmos dextrans, pharmaceutical biopoly …
  • Terna Energy SA (TENERGY):企業の財務・戦略的SWOT分析
    Terna Energy SA (TENERGY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • The Seibels Bruce Group Inc:企業の戦略・SWOT・財務分析
    The Seibels Bruce Group Inc - Strategy, SWOT and Corporate Finance Report Summary The Seibels Bruce Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • French National Institute of Health and Medical Research:製薬・医療:M&Aディール及び事業提携情報
    Summary French National Institute of Health and Medical Research (INSERM) is a biomedical research institute that conducts research in biology, medicine and public health. The institute offers research in the therapeutic areas of neurosciences, cognitive sciences, neurology, psychiatry, cancer, immu …
  • CESC Limited (CESC):企業の財務・戦略的SWOT分析
    CESC Limited (CESC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Digirad Corp (DRAD):医療機器:M&Aディール及び事業提携情報
    Summary Digirad Corp (Digirad) is a medical device company that provides mobile and on-site imaging solutions. The company provides camera products such as ergo, cardius x-ACT, cardius 2 XPO, corcam, quantumcam, cardius 3 XPO, and others. It provides diagnostic services such as nuclear cardiology, u …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆